Xu W - Search Results

1

Comparison between Fluorescence Imaging and Elemental Analysis to Determine Biodistribution of Inorganic Nanoparticles with Strong Light Absorption.

Tamarov K, Wang JT, Kari J, Happonen E, Vesavaara I, Niemelä M, Perämäki P, Al-Jamal KT, Xu W, Lehto VP. Tamarov K, et al. Among authors: xu w. ACS Appl Mater Interfaces. 2021 Sep 1;13(34):40392-40400. doi: 10.1021/acsami.1c11875. Epub 2021 Aug 16. ACS Appl Mater Interfaces. 2021. PMID: 34405988 Free PMC article.

2

Surface chemistry, reactivity, and pore structure of porous silicon oxidized by various methods.

Riikonen J, Salomäki M, van Wonderen J, Kemell M, Xu W, Korhonen O, Ritala M, MacMillan F, Salonen J, Lehto VP. Riikonen J, et al. Among authors: xu w. Langmuir. 2012 Jul 17;28(28):10573-83. doi: 10.1021/la301642w. Epub 2012 Jul 2. Langmuir. 2012. PMID: 22671967

3

Mesoporous systems for poorly soluble drugs.

Xu W, Riikonen J, Lehto VP. Xu W, et al. Int J Pharm. 2013 Aug 30;453(1):181-97. doi: 10.1016/j.ijpharm.2012.09.008. Epub 2012 Sep 8. Int J Pharm. 2013. PMID: 22990124 Review.

4

Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.

Huotari A, Xu W, Mönkäre J, Kovalainen M, Herzig KH, Lehto VP, Järvinen K. Huotari A, et al. Among authors: xu w. Int J Pharm. 2013 Sep 15;454(1):67-73. doi: 10.1016/j.ijpharm.2013.06.063. Epub 2013 Jul 5. Int J Pharm. 2013. PMID: 23834832

5

Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.

Rytkönen J, Arukuusk P, Xu W, Kurrikoff K, Langel U, Lehto VP, Närvänen A. Rytkönen J, et al. Among authors: xu w. Mol Pharm. 2014 Feb 3;11(2):382-90. doi: 10.1021/mp4002624. Epub 2013 Dec 30. Mol Pharm. 2014. PMID: 24341621

6

Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration.

Näkki S, Rytkönen J, Nissinen T, Florea C, Riikonen J, Ek P, Zhang H, Santos HA, Närvänen A, Xu W, Lehto VP. Näkki S, et al. Among authors: xu w. Acta Biomater. 2015 Feb;13:207-15. doi: 10.1016/j.actbio.2014.11.019. Epub 2014 Nov 20. Acta Biomater. 2015. PMID: 25463492

7

Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.

Riikonen J, Correia A, Kovalainen M, Näkki S, Lehtonen M, Leppänen J, Rantanen J, Xu W, Araújo F, Hirvonen J, Järvinen K, Santos HA, Lehto VP. Riikonen J, et al. Among authors: xu w. Biomaterials. 2015 Jun;52:44-55. doi: 10.1016/j.biomaterials.2015.02.014. Epub 2015 Feb 21. Biomaterials. 2015. PMID: 25818412

8

Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy.

Xu W, Thapa R, Liu D, Nissinen T, Granroth S, Närvänen A, Suvanto M, Santos HA, Lehto VP. Xu W, et al. Mol Pharm. 2015 Nov 2;12(11):4038-47. doi: 10.1021/acs.molpharmaceut.5b00473. Epub 2015 Oct 5. Mol Pharm. 2015. PMID: 26390039

9

Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.

Korhonen E, Rönkkö S, Hillebrand S, Riikonen J, Xu W, Järvinen K, Lehto VP, Kauppinen A. Korhonen E, et al. Among authors: xu w. Eur J Pharm Biopharm. 2016 Mar;100:1-8. doi: 10.1016/j.ejpb.2015.11.020. Epub 2015 Dec 11. Eur J Pharm Biopharm. 2016. PMID: 26686646

10

Temperature responsive porous silicon nanoparticles for cancer therapy - spatiotemporal triggering through infrared and radiofrequency electromagnetic heating.

Tamarov K, Xu W, Osminkina L, Zinovyev S, Soininen P, Kudryavtsev A, Gongalsky M, Gaydarova A, Närvänen A, Timoshenko V, Lehto VP. Tamarov K, et al. Among authors: xu w. J Control Release. 2016 Nov 10;241:220-228. doi: 10.1016/j.jconrel.2016.09.028. Epub 2016 Sep 26. J Control Release. 2016. PMID: 27686581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28,065 results

Search Page